Literature DB >> 1554835

Systemic candidal infections associated with use of peripheral venous catheters in neonates: a 9-year experience.

E Leibovitz1, A Iuster-Reicher, M Amitai, B Mogilner.   

Abstract

The clinical courses of 25 infants with systemic candidiasis who were treated in the neonatal intensive care unit at Kaplan Hospital, Rehovot, Israel, during the period 1980-1989 were retrospectively analyzed. Twenty-three (92%) weighted less than 1,500 g at birth. Candidemia was associated with prolonged antibiotic therapy, hyperalimentation, and intravenous fat emulsions in all cases and with previous tracheal intubation in 80% of cases. Only one infant had a central venous catheter placed; for all others, hyperalimentation was administered by means of peripheral intravenous catheters. The mean age at onset of systemic candidiasis was 30 +/- 14 days, although an earlier onset (25 +/- 8 days) was noted during the last 3 years of the study period. Candida species were isolated from the blood of 24 infants and from the urine of 10 infants. Microscopic examination of the urine was positive for Candida organisms for three infants and led to a rapid diagnosis. Candidal skin abscesses were present in 11 infants (44%); for two of these infants, the early occurrence of such abscesses prompted the initiation of therapy before confirmation of the diagnosis of systemic candidiasis. All infants were treated with intravenous amphotericin B and oral 5-fluorocytosine. The mortality rate was 20%, but death was directly attributable to candidemia in only three infants (12%).

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1554835     DOI: 10.1093/clinids/14.2.485

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  14 in total

1.  Risk factors for candidemia in critically ill infants: a matched case-control study.

Authors:  Kristina N Feja; Fann Wu; Kevin Roberts; Maureen Loughrey; Mirjana Nesin; Elaine Larson; Phyllis Della-Latta; Janet Haas; Jeannie Cimiotti; Lisa Saiman
Journal:  J Pediatr       Date:  2005-08       Impact factor: 4.406

2.  Chronic urinary tract infection due to Candida utilis.

Authors:  K C Hazen; G W Theisz; S A Howell
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

3.  Pharmacokinetics, safety, and tolerability of caspofungin in children and adolescents.

Authors:  Thomas J Walsh; Peter C Adamson; Nita L Seibel; Patricia M Flynn; Michael N Neely; Cindy Schwartz; Aziza Shad; Sheldon L Kaplan; Maureen M Roden; Julie A Stone; Alisha Miller; Susan K Bradshaw; Susan X Li; Carole A Sable; Nicholas A Kartsonis
Journal:  Antimicrob Agents Chemother       Date:  2005-11       Impact factor: 5.191

4.  Nonperinatal nosocomial transmission of Candida albicans in a neonatal intensive care unit: prospective study.

Authors:  S E Reef; B A Lasker; D S Butcher; M M McNeil; R Pruitt; H Keyserling; W R Jarvis
Journal:  J Clin Microbiol       Date:  1998-05       Impact factor: 5.948

Review 5.  Antifungal agents in neonatal systemic candidiasis.

Authors:  J N van den Anker; N M van Popele; P J Sauer
Journal:  Antimicrob Agents Chemother       Date:  1995-07       Impact factor: 5.191

6.  Relevance of culturing Candida species from intravascular catheters.

Authors:  R Khatib; J A Clark; L E Briski; F M Wilson
Journal:  J Clin Microbiol       Date:  1995-06       Impact factor: 5.948

Review 7.  Clinical microbiology of bacterial and fungal sepsis in very-low-birth-weight infants.

Authors:  David Kaufman; Karen D Fairchild
Journal:  Clin Microbiol Rev       Date:  2004-07       Impact factor: 26.132

Review 8.  Antifungals in systemic neonatal candidiasis.

Authors:  Daniel A C Frattarelli; Michael D Reed; George P Giacoia; Jacob V Aranda
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 9.  Antifungal agents in neonates: issues and recommendations.

Authors:  Benito Almirante; Dolors Rodríguez
Journal:  Paediatr Drugs       Date:  2007       Impact factor: 3.022

10.  Investigation of the sequence of colonization and candidemia in nonneutropenic patients.

Authors:  A Voss; R J Hollis; M A Pfaller; R P Wenzel; B N Doebbeling
Journal:  J Clin Microbiol       Date:  1994-04       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.